Aldeyra refocuses pipeline on next-gen RASP modulators despite positive phase II success
ADX-248, which replaces ADX-743, is being developed for the treatment of metabolic inflammation, including obesity and hypertriglyceridemia
ADX-248, which replaces ADX-743, is being developed for the treatment of metabolic inflammation, including obesity and hypertriglyceridemia
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
New study presents a human-relevant stress model for assessing potential therapeutics
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Subscribe To Our Newsletter & Stay Updated